CNS Pharmaceuticals (CNSP) Short Interest Ratio & Short Volume

$0.22
-0.01 (-4.41%)
(As of 05/17/2024 ET)

CNS Pharmaceuticals Short Interest Data

Current Short Volume
31,200 shares
Previous Short Volume
23,100 shares
Change Vs. Previous Month
+35.06%
Dollar Volume Sold Short
$6,552.00
Short Interest Ratio / Days to Cover
0.1
Last Record Date
April 30, 2024
Outstanding Shares
11,852,000 shares
Float Size
10,140,000 shares
Short Percent of Float
0.31%
Today's Trading Volume
197,891 shares
Average Trading Volume
342,598 shares
Today's Volume Vs. Average
58%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling CNS Pharmaceuticals ?

Sign up to receive the latest short interest report for CNS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CNSP Short Interest Over Time

CNSP Days to Cover Over Time

CNSP Percentage of Float Shorted Over Time

CNS Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202431,200 shares $6,552.00 +35.1%0.3%0.1 $0.21
4/15/202423,100 shares $5,530.14 -53.8%0.2%0.1 $0.24
3/31/202450,000 shares $18,100.00 -51.8%0.5%0.1 $0.36
3/15/2024103,800 shares $36,983.94 +91.5%1.3%0.3 $0.36
2/29/202454,200 shares $15,067.60 -47.2%0.7%0.1 $0.28
2/15/2024102,600 shares $29,035.80 -87.2%1.3%0.3 $0.28
1/31/2024802,400 shares $198,995.20 +317.1%10.2%2.6 $0.25
1/15/2024192,400 shares $179,894.00 -10.8%3.1%1.6 $0.94
12/31/2023215,700 shares $273,939.00 +298.0%3.5%2.1 $1.27
12/15/202354,200 shares $93,766.00 +30.6%0.9%0.5 $1.73
11/30/202341,500 shares $86,320.00 +75.1%0.8%0.6 $2.08
11/15/202323,700 shares $45,504.00 -50.3%0.5%0.3 $1.92
10/31/202347,700 shares $98,739.00 -36.6%1.2%0.3 $2.07
10/15/202375,200 shares $101,520.00 +22.7%1.8%0.5 $1.35
9/30/202361,300 shares $69,882.00 -8.5%1.5%0.5 $1.14
9/15/202367,000 shares $100,500.00 -45.2%1.6%0.4 $1.50
8/31/2023122,300 shares $209,133.00 +69.6%3.0%0.6 $1.71
8/15/202372,100 shares $123,291.00 -3.1%1.8%0.2 $1.71
7/31/202374,400 shares $168,144.00 +11.4%1.8%0.2 $2.26
7/15/202366,800 shares $142,952.00 -70.0%1.6%0 $2.14
6/30/2023222,600 shares $496,398.00 +7.2%5.5%0.1 $2.23
6/15/2023207,600 shares $448,416.00 -9.4%5.1%0.1 $2.16
5/31/2023229,100 shares $421,544.00 +91.6%5.7%0.1 $1.84
5/15/2023119,600 shares $166,244.00 -44.6%3.0%0 $1.39
4/30/2023215,800 shares $325,858.00 +306.4%10.0%0.1 $1.51
4/15/202353,100 shares $124,785.00 +410.6%3.1%0 $2.35
3/31/202310,400 shares $10,400.00 -57.6%0.6%0 $1.00
3/15/202324,500 shares $30,380.00 +49.4%2.3%0.6 $1.24
2/28/202316,400 shares $30,340.00 +62.4%1.6%0.4 $1.85
2/15/202310,100 shares $17,372.00 +206.1%1.0%0.3 $1.72
1/31/20233,300 shares $7,293.00 +153.9%0.3%0.1 $2.21
1/15/20231,300 shares $3,120.00 -63.9%0.1%0.1 $2.40
12/30/20223,600 shares $8,640.00 -65.4%0.3%0.2 $2.40
12/15/202210,400 shares $26,520.00 -2.8%0.8%0.6 $2.55
11/30/202210,700 shares $32,421.00 -88.5%1.1%0.7 $3.03
11/15/202293,200 shares $17,717.32 +24.4%N/A0.5 $0.19
10/31/202274,900 shares $11,984.00 +21.2%N/A0.4 $0.16
10/15/202261,800 shares $12,656.64 -65.7%N/A0.3 $0.20
9/30/2022180,000 shares $32,220.00 -14.6%N/A0.7 $0.18
9/15/2022210,800 shares $51,856.80 +15.0%N/A0.4 $0.25
Claim Your Complimentary Bitcoin Reward (Ad)

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

CNSP Short Interest - Frequently Asked Questions

What is CNS Pharmaceuticals' current short interest?

Short interest is the volume of CNS Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 31,200 shares of CNSP short. 0.31% of CNS Pharmaceuticals' shares are currently sold short. Learn More on CNS Pharmaceuticals' current short interest.

What is a good short interest percentage for CNS Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.31% of CNS Pharmaceuticals' floating shares are currently sold short.

Is CNS Pharmaceuticals' short interest increasing or decreasing?

CNS Pharmaceuticals saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 31,200 shares, an increase of 35.1% from the previous total of 23,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is CNS Pharmaceuticals' float size?

CNS Pharmaceuticals currently has issued a total of 11,852,000 shares. Some of CNS Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CNS Pharmaceuticals currently has a public float of 10,140,000 shares.

How does CNS Pharmaceuticals' short interest compare to its competitors?

0.31% of CNS Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CNS Pharmaceuticals: Clearmind Medicine Inc. (5.51%), Dermata Therapeutics, Inc. (1.28%), Avenue Therapeutics, Inc. (3.26%), Altamira Therapeutics Ltd. (6.57%), Galmed Pharmaceuticals Ltd. (1.49%), Salarius Pharmaceuticals, Inc. (1.65%), Sonoma Pharmaceuticals, Inc. (0.30%), Notable Labs, Ltd. (0.08%), Allarity Therapeutics, Inc. (10.38%), Onconetix, Inc. (0.31%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short CNS Pharmaceuticals stock?

Short selling CNSP is an investing strategy that aims to generate trading profit from CNS Pharmaceuticals as its price is falling. CNSP shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CNS Pharmaceuticals?

A short squeeze for CNS Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNSP, which in turn drives the price of the stock up even further.

How often is CNS Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNSP, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CNSP) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners